(Q40667901)

22 September 2017

1 reference

title

Development of antisense therapeutics. Implications for cancer gene therapy (English)

1 reference

22 September 2017

0 references

1 reference

Milligan JF

1

1 reference

22 September 2017

Jones RJ

series ordinal

2

1 reference

22 September 2017

Froehler BC

series ordinal

3

1 reference

22 September 2017

Matteucci MD

series ordinal

4

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 May 1994

1 reference

Annals of the New York Academy of Sciences

22 September 2017

published in

1 reference

22 September 2017

volume

716

1 reference

22 September 2017

page(s)

228-241

1 reference

Comparative evaluation of seven oligonucleotide analogues as potential antisense agents.

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB21715.X

Phosphorothioate oligodeoxynucleotides—anti-sense inhibitors of gene expression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB21715.X

Expression of deoxyadenosine and deoxyguanosine toxicity at different stages of lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB21715.X

Oligonucleoside methylphosphonates as antisense reagents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB21715.X

Dynamics of the internalization of phosphodiester oligodeoxynucleotides in HL60 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB21715.X

Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB21715.X

Specific inhibition of human immunodeficiency virus type 1 replication by antisense oligonucleotides: an in vitro model for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB21715.X

Long-term treatment of human immunodeficiency virus-infected cells with antisense oligonucleotide phosphorothioates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB21715.X

Intracellular distribution of microinjected antisense oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB21715.X

Use of an antisense oligonucleotide to inhibit expression of a mutated human procollagen gene (COL1A1) in transfected mouse 3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB21715.X

Partial protection of oncogene, anti-sense oligodeoxynucleotides against serum nuclease degradation using terminal methylphosphonate groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB21715.X

Implications of ribozyme kinetics for targeting the cleavage of specific RNA molecules in vivo: more isn't always better

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB21715.X

An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB21715.X

Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides: an in vitro study relevant to bone marrow purging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB21715.X

In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB21715.X

Human promyelocytic leukemia HL-60 cell proliferation and c-myc protein expression are inhibited by an antisense pentadecadeoxynucleotide targeted against c-myc mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB21715.X

Antiproliferative effects of a c-myc antisense oligonucleotide on human arterial smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB21715.X

Inhibitory effects of antisense oligodeoxynucleotides targeting c-myc mRNA on smooth muscle cell proliferation and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB21715.X

Inhibition of smooth muscle cell proliferation by an antisense oligodeoxynucleotide targeting the messenger RNA encoding proliferating cell nuclear antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB21715.X

A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB21715.X

10.1111/J.1749-6632.1994.TB21715.X

21 January 2018

Identifiers

DOI

1 reference

22 September 2017

1 reference